Abstract
To evaluate genetic testing use in infants with congenital diaphragmatic hernia (CDH) over the past decade to better inform future practices and individualize prognostication and management. A retrospective cohort study was performed of all infants with CDH enrolled in the Pulmonary Hypoplasia Program at Children's Hospital of Philadelphia, born between January 2011 and February 2021. For each infant, demographic information, prenatal and postnatal history, and genetic testing were reviewed. The charts of 411 infants were analyzed. Overall, 22% (n=89) were complex/syndromic and 78% (n=322) were isolated/nonsyndromic. Mortality was significantly higher in complex/syndromic infants (P<.001) and in infants with diagnostic genetic testing (P<.001). Microarray was diagnostic in 9% (n=34/399) and exome sequencing was diagnostic in 38% (n=15/39). Genetic testing was diagnostic in 57% (n=51/89) of complex/syndromic infants, but in only 2% of isolated/nonsyndromic infants (n=8/322). Overall, genetic testing was diagnostic in 14% (n=56). The high diagnostic rate in this cohort highlights the utility of comprehensive genetic testing in infants with CDH. However, 43% of complex/syndromic and 98% of isolated/nonsyndromic infants do not have a genetic etiology identified. This finding underscores the need for additional genetic and genomic studies (eg, whole genome, RNA sequencing) to identify novel genes and mutational mechanisms (single genes, regulatory elements, complex traits) that will allow for improved diagnostic rates and ultimately individualized management of infants with CDH.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
